{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:39:14Z","timestamp":1789915154470,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union's Seventh Framework Programme","award":["602030"],"award-info":[{"award-number":["602030"]}]},{"name":"Paediatric Oncology Centre Society for Research"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejca.2016.09.023","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T07:00:29Z","timestamp":1478242829000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study"],"prefix":"10.1016","volume":"69","author":[{"given":"Eva","family":"Clemens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0964-0007","authenticated-orcid":false,"given":"Andrica C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia F.","family":"Pluijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"am Zehnhoff-Dinnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim J.","family":"Tissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline J.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"van Dulmen-den Broeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine","family":"Bresters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Versluys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontien C.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen J.","family":"van der Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"van Grotel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2016.09.023_bib1","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.297.24.2705","article-title":"Medical assessment of adverse health outcomes in long-term survivors of childhood cancer","volume":"297","author":"Geenen","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2016.09.023_bib2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","article-title":"Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions","volume":"25","author":"Knight","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPH.0b013e31815d1d83","article-title":"Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens","volume":"30","author":"Dean","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib5","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib6","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1542\/peds.2009-1597","article-title":"Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group","volume":"125","author":"Grewal","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejca.2016.09.023_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1081\/CNV-200055951","article-title":"Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance system","volume":"23","author":"Stohr","year":"2005","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ejca.2016.09.023_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/14992027.2010.485595","article-title":"Long term hearing degeneration after platinum-based chemotherapy in childhood","volume":"49","author":"Einarsson","year":"2010","journal-title":"Int J Audiol"},{"key":"10.1016\/j.ejca.2016.09.023_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system","volume":"19","author":"Brock","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPH.0b013e318059c220","article-title":"Ototoxicity from cisplatin therapy in childhood cancer","volume":"29","author":"Coradini","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib11","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1097\/MPH.0000000000000028","article-title":"Cisplatin-induced hearing loss: the need for a long-term evaluating system","volume":"36","author":"Yasui","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib12","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose","volume":"40","author":"Li","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.24138","article-title":"Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients","volume":"59","author":"Yancey","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/pbc.21875","article-title":"Ototoxicity in children treated for osteosarcoma","volume":"52","author":"Lewis","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pbc.20379","article-title":"Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: results of the SFOP NBL90 study","volume":"45","author":"Bergeron","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib16","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/00005537-199911000-00016","article-title":"Ototoxic impact of cisplatin in pediatric oncology patients","volume":"109","author":"Berg","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejca.2016.09.023_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejca.2016.09.023_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.heares.2010.10.011","article-title":"Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea","volume":"272","author":"Hirose","year":"2011","journal-title":"Hear Res"},{"key":"10.1016\/j.ejca.2016.09.023_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/03005368209081455","article-title":"Ultrastructural and electrophysiological studies of acute ototoxic effects of furosemide","volume":"16","author":"Forge","year":"1982","journal-title":"Br J Audiol"},{"key":"10.1016\/j.ejca.2016.09.023_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0277-5379(83)90398-X","article-title":"Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration","volume":"19","author":"Vermorken","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib21","first-page":"191","article-title":"Cisplatin and cranial irradiation-related hearing loss in children","volume":"12","author":"Warrier","year":"2012","journal-title":"Ochsner J"},{"key":"10.1016\/j.ejca.2016.09.023_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MPH.0b013e3181cb8593","article-title":"Late onset hearing loss: a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens","volume":"32","author":"Kolinsky","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2011.36.9744","article-title":"Carboplatin-associated ototoxicity in children with retinoblastoma","volume":"30","author":"Qaddoumi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2013.51.2038","article-title":"Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales\u2014a report from the Children's Oncology Group","volume":"32","author":"Landier","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3892\/ol.2012.997","article-title":"Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients","volume":"5","author":"Nitz","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejca.2016.09.023_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00106-005-1368-1","article-title":"The \u201cMuenster classification\u201d of high frequency hearing loss following cisplatin chemotherapy","volume":"55","author":"Schmidt","year":"2007","journal-title":"HNO"},{"key":"10.1016\/j.ejca.2016.09.023_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pbc.20673","article-title":"Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters","volume":"47","author":"Lanvers-Kaminsky","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pbc.24830","article-title":"Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma","volume":"61","author":"Bass","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib29","unstructured":"Clemens E, de Vries AC, Am Zehnhoff-Dinnesen A, Tissing W, Loonen J, Pluijm SM, et\u00a0al. Hearing loss after platinum-treatment is irreversible at long-term follow-up in non-cranial irradiated CCS, a DCOG study. Manuscript submitted for publication."},{"key":"10.1016\/j.ejca.2016.09.023_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/bjc.1990.208","article-title":"Ototoxicity of cisplatinum in children and adolescents","volume":"61","author":"Skinner","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib31","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1002\/cncr.29604","article-title":"Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: results from the St. Jude Lifetime Cohort Study","volume":"121","author":"Brinkman","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib32","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/pbc.24560","article-title":"Speech recognition and frequency of hearing loss in patients treated for cancer in childhood","volume":"60","author":"Liberman","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1096-911X(199607)27:1<26::AID-MPO6>3.0.CO;2-W","article-title":"Ototoxicity in children with malignant brain tumors treated with the \u201c8 in 1\u201d chemotherapy protocol","volume":"27","author":"Ilveskoski","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pbc.21898","article-title":"Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma","volume":"52","author":"Jehanne","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib35","series-title":"Sodium thiosulfate in preventing hearing loss in young patients receiving cisplatin for newly diagnosed germ cell tumor, hepatoblastoma, medulloblastoma, neuroblastoma, osteosarcoma and other malignancy","author":"ClinicalTrialsgov","year":"2016"},{"key":"10.1016\/j.ejca.2016.09.023_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00381-010-1300-1","article-title":"Carboplatin and ototoxicity: hearing loss rates among survivors of childhood medulloblastoma","volume":"27","author":"Musial-Bright","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ejca.2016.09.023_bib37","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/pbc.25123","article-title":"Incidence of platinum-induced ototoxicity in pediatric patients in Quebec","volume":"61","author":"Peleva","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2016.09.023_bib38","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1200\/JCO.2009.24.4228","article-title":"Practical grading system for evaluating cisplatin ototoxicity in children","volume":"28","author":"Chang","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2016.09.023_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/bmb\/63.1.171","article-title":"Auditory development and the role of experience","volume":"63","author":"Moore","year":"2002","journal-title":"Br Med Bull"},{"issue":"Suppl.","key":"10.1016\/j.ejca.2016.09.023_bib40","first-page":"54","article-title":"Ototoxic side-effects of high doses of frusemide in patients with uraemia","volume":"47","author":"Wigand","year":"1971","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejca.2016.09.023_bib41","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-91-5-744","article-title":"Furosemide-induced ototoxicity","volume":"91","author":"Gallagher","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2016.09.023_bib42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00007611-197801000-00029","article-title":"Deafness associated with oral furosemide","volume":"71","author":"Rifkin","year":"1978","journal-title":"South Med J"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916324698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916324698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T04:52:42Z","timestamp":1589691162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916324698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":42,"alternative-id":["S0959804916324698"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.09.023","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}